Pagina 5 - I migliori medici per il trattamento di Cancro esofageo - TOP-133 medici

Il medico è specializzato in oncologia con un focus su metodi innovativi di trattamento del cancro e cura personalizzata del paziente. Con oltre 15 anni di esperienza, il medico ha contribuito significativamente allo sviluppo di nuovi protocolli di chemioterapia ed è stato coinvolto in numerosi studi clinici mirati a migliorare i risultati dei pazienti. Il medico è certificato in oncologia e ha pubblicato ampiamente in riviste peer-reviewed, condividendo intuizioni sugli ultimi progressi nella ricerca sul cancro. Inoltre, il medico ha ricevuto numerosi premi per l'eccellenza nella pratica clinica e nella ricerca.<\/p>

Il medico è un oncologo altamente qualificato specializzato sia in oncologia medica che in oncologia radioterapica. Laureato presso la Scuola di Medicina di Firenze in Italia, il medico è certificato in Israele e ha completato diversi corsi avanzati, tra cui l'Esame del Consiglio della Comunità Europea in Medicina e il corso di insegnamento ESTRO sulle tecniche moderne di brachiterapia.<\/p>

Con una vasta esperienza professionale, il medico ha servito come medico senior e capo dei servizi oncologici in varie istituzioni. Attualmente, il medico dirige il Servizio di Malattie Maligne Gastrointestinali ed è responsabile del Dipartimento di Radioterapia presso il Centro Medico Rambam a Haifa, Israele.<\/p>

La dottoressa è un'oncologa presso il Centro Medico Hadassah, avendo conseguito un Dottorato in Scienze Mediche presso l'Università Ebraica di Gerusalemme. Ha completato un tirocinio presso il prestigioso Centro Oncologico Sloan-Kettering di New York, migliorando la sua esperienza in oncologia.<\/p>

Nel 1994, è diventata capo dell'Istituto di Oncologia e successivamente, nel 1998, ha guidato il Centro di Trattamento del Cancro al Seno. Entro il 2006, è stata nominata Professore del Dipartimento di Oncologia presso l'Università Ebraica. È attivamente coinvolta con diverse organizzazioni internazionali sul cancro ed è stata riconosciuta con una borsa di studio dalla Scuola Medica Hadassah.<\/p>

Il medico è un radioterapista altamente esperto, specializzato in tecniche avanzate di terapia radiante per il trattamento del cancro. Con oltre 15 anni di pratica, ha contribuito in modo significativo al campo attraverso la ricerca e le sperimentazioni cliniche, con l'obiettivo di migliorare i risultati dei pazienti. Il medico è stato riconosciuto per la sua esperienza in radiochirurgia stereotassica e terapia radiante modulata in intensità, fornendo cure all'avanguardia ai pazienti. Ha pubblicato numerosi articoli sottoposti a revisione paritaria ed è un frequente relatore in conferenze internazionali di oncologia.<\/p>

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

La dottoressa ha una vasta esperienza nel trattamento dei tumori gastrointestinali, del cancro ai polmoni e delle neoplasie ginecologiche. È un'esperta riconosciuta nella diagnostica e nella cura complessa delle malattie neoplastiche maligne.<\/p>

Autrice di oltre 30 articoli scientifici nazionali e internazionali sul trattamento delle malignità, è membro della Società Europea di Oncologia Medica e di altre associazioni professionali.<\/p>

Laureata all'Università di Istanbul nel 1993, è stata promossa a Professore Associato nel 2010 e attualmente lavora come oncologa principale presso il LIV Hospital. Il suo lavoro include posizioni presso l'Ospedale di Formazione e Ricerca di Taksim, l'Ospedale di Kayseri, l'Ospedale di Istanbul e il Centro Medico Neolife.<\/p>

Il medico ha completato la formazione di specializzazione in Oncologia Radioterapica presso la Facoltà di Medicina dell'Università di Marmara dal 2012 al 2016. Prima di questo, il medico ha completato una laurea in Medicina, insegnata in inglese, presso la stessa istituzione dal 2004 al 2011. Il medico ha una solida base nell'educazione medica, iniziando con l'istruzione superiore presso la Scuola Numero Sedici di Shirvan in Azerbaigian dal 1998 al 2004.<\/p>

Member of SICOB - Italian Society of Obesity Surgery and ACOI - Association of Italian Hospital Surgeons                                               

Dr Braun is a board-certified general surgeon with over 25 years of experience specializing in gastrointestinal surgery, particularly in the treatment of gastroesophageal reflux disease (GERD) through Fundoplication surgery. He has performed over 500 successful Nissen and Toupet Fundoplication procedures, with a focus on minimally invasive laparoscopic techniques. His expertise extends to diagnosing complex cases of GERD and offering comprehensive treatment plans to improve patient outcomes.

He has carried out his main training experiences in various international institutions and specialization courses in general and digestive system surgery, including a two-year training internship at Johns Hopkins University, Division of Hepatobiliary Pancreatic Surgery and numerous courses in Madrid, with Prof. E. Moreno Gonzales (Curso Internacional de Actualizaciòn en chirurgia General y del Aparato Digestivo) or in New Orleans (Medical Education at the 90th Annual Clinical Congress of the American College of Surgeons).

Dr. Braun has extensive expertise in the field of digestive surgery. He has focused on implementing advanced protocols and optimizing surgical techniques, while maintaining high standards of safety and patient care. He has collaborated with a multidisciplinary team to provide an integrated and personalized approach in the management of obese or digestive disorder patients, improving quality of life and reducing post-operative complications.

Guida uno dei Centri ad Alto Volume per la chirurgia esofagea più riconosciuti d’Italia – più di 2.000 interventi chirurgici annuali presso il San Raffaele.

• Responsabile del Dipartimento di Chirurgia Gastrointestinale dal 2014
• Specializzato in procedure del tratto digerente superiore sia aperte che minimamente invasive
• Oltre 300 pubblicazioni sulle malattie dell'esofago
• Membro della International Society for Diseases of the Esophagus

Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.

Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.

In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.

Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.

Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).

Prof. Filippini began his career in 1980 and has been teaching at the University of Chieti since the 1990s in the fields of General Surgery, Microsurgery, Reconstructive Surgery, Vascular Surgery, Orthopedics, and Gynecology. His primary focus is oncological surgery, particularly specializing in "The surgical treatment of locally advanced tumors and multi-organ resections." He has enriched his expertise by visiting prominent reference centers in the United States, including the Memorial Sloan Kettering Cancer Center in Manhattan, New York City. There, he delved into minimally invasive, laparoscopic, and microsurgical techniques under the guidance of esteemed mentors such as John Daly, Michele Gagner, and Murray Brennan. Additionally, in 2005, he further expanded his skills at the City of Hope Oncology Center in Los Angeles, focusing on robotic surgery in oncology.

In 1980, Prof. Filippini graduated in Medicine and Surgery from the G. D'Annunzio University of Chieti in Italy with honors, presenting an experimental thesis on lympho-venous anastomosis using microsurgical techniques. He completed his specialization in general surgery at the University of Pisa with distinction after five years. In 1990, he obtained another specialization in Plastic and Reconstructive Surgery from the University of Padua in Italy, where he maintained a stellar academic record.

Prof. Filippini has presented at numerous national and international conferences and authored over 100 scientific publications. Additionally, he has co-authored two monographs.